CA
AGN

Callahan Advisors’s Allergan Inc AGN Stock Holding History

Callahan Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,550
Closed -$2.22M – 131
2020
Q1 		$2.22M Sell
12,550
-62
-0.5% -$11K 0.47% 54
2019
Q4 		$2.41M Sell
12,612
-43
-0.3% -$8.22K 0.39% 60
2019
Q3 		$2.13M Sell
12,655
-119
-0.9% -$20K 0.37% 62
2019
Q2 		$2.14M Sell
12,774
-2,700
-17% -$452K 0.38% 59
2019
Q1 		$2.27M Buy
15,474
+75
+0.5% +$11K 0.42% 59
2018
Q4 		$2.06M Sell
15,399
-64
-0.4% -$8.55K 0.44% 54
2018
Q3 		$2.94M Buy
15,463
+120
+0.8% +$22.9K 0.55% 54
2018
Q2 		$2.56M Buy
15,343
+70
+0.5% +$11.7K 0.5% 56
2018
Q1 		$2.57M Buy
15,273
+10,773
+239% +$1.81M 0.53% 53
2017
Q4 		$736K Buy
+4,500
New +$736K 0.15% 90
2014
Q2 		– Sell
-6,282
Closed -$780K – 125
2014
Q1 		$780K Buy
6,282
+51
+0.8% +$6.21K 0.27% 81
2013
Q4 		$692K Buy
6,231
+155
+3% +$14.8K 0.24% 81
2013
Q3 		$550K Sell
6,076
-360
-6% -$32.3K 0.21% 86
2013
Q2 		$542K Buy
+6,436
New +$668K 0.22% 83

Callahan Advisors's AGN Position: Q2 2020 in Review

Callahan Advisors sold out of Allergan Inc (AGN) in Q2 2020, closing a stake of 12,550 shares — an estimated $2.22M sold.

Callahan Advisors first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $2.94M in Q3 2018. 0 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Callahan Advisors reported no remaining Allergan Inc position as of Q2 2020 after selling out during the quarter.
  • Callahan Advisors sold 12,550 Allergan Inc shares in Q2 2020, an estimated $2.22M.
  • Callahan Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 14 quarters.
  • Callahan Advisors's Allergan Inc position peaked at $2.94M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2020.

Based on Callahan Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.